4.6 Article

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia

Lieke H. H. Meeter et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Clinical Neurology

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias

Samir Abu-Rumeileh et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Clinical Neurology

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease

Piotr Lewczuk et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Article Clinical Neurology

Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder

Oskar Hansson et al.

NEUROLOGY (2017)

Article Biochemistry & Molecular Biology

Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair

Edyta Merisson et al.

NEUROCHEMISTRY INTERNATIONAL (2016)

Article Clinical Neurology

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

Lieke H. Meeter et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Article Multidisciplinary Sciences

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Pashtun Shahim et al.

SCIENTIFIC REPORTS (2016)

Article Clinical Neurology

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

Jeppe Romme Christensen et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Article Multidisciplinary Sciences

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

Johanna Gaiottino et al.

PLOS ONE (2013)

Letter Clinical Neurology

Plasma tau levels in Alzheimer's disease

Henrik Zetterberg et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Article Biochemistry & Molecular Biology

Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer's Disease in Vitro

Che-Chuan Yang et al.

ACS CHEMICAL NEUROSCIENCE (2011)

Article Neurosciences

CSF Neurofilament Proteins Levels are Elevated in Sporadic Creutzfeldt-Jakob Disease

Jeroen J. J. van Eijk et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Biochemical Research Methods

Magnetically enhanced high-specificity virus detection using magnetic nanoparticles with antibodies as labeling markers

S. Y. Yang et al.

JOURNAL OF VIROLOGICAL METHODS (2010)

Article Materials Science, Multidisciplinary

Dual immobilization and magnetic manipulation of magnetic nanoparticles

S. Y. Yang et al.

JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2008)

Article Clinical Neurology

CSF neurofilament proteins in the differential diagnosis of dementia

D. de Jong et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)

Article Physics, Applied

Wash-free immunomagnetic detection for serum through magnetic susceptibility reduction

Chin-Yih Hong et al.

APPLIED PHYSICS LETTERS (2007)

Article Biochemical Research Methods

An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid

WJA Van Geel et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2005)

Review Clinical Neurology

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

CE Teunissen et al.

LANCET NEUROLOGY (2005)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY